The European Medicines Agency Ema has recommended the authorization of two treatments for Covid-19: the monoclonal antibody Sotrovimab (Xevudy *) and the anti-inflammatory Anakinra (Kineret *), an immunosuppressive medicine already authorized in the EU for various inflammatory conditions .
Covid Watch
Anti Covid pills work but they cannot replace vaccines: here’s why
by Aureliano Stingi
Signs for Sotrovimab – Xevudy
The EU regulatory body, in a note announcing the green light, explains that Sotrovimab is indicated to treat Covid-19 in adults and adolescents from 12 years of age and weighing at least 40 kilograms, who do not require oxygen. and that they are at increased risk of the disease becoming severe.
Covid, here’s how we manage the disease
by Letizia Gabaglio
When can Anakinra (Kineret) be used
The indication of anakinra has instead been extended to include the treatment of Covid-19 in adult patients with pneumonia who require supplemental oxygen (low or high flow oxygen) and who are at risk of developing severe respiratory failure, as determined by levels in the blood of a protein called suPar.
Anakinra, how the rheumatoid arthritis drug works which could also be useful against Covid
by Giuseppe del Bello
Denmark recommends the Merck pill
Denmark has recommended anti-Covid treatment with the Merck pill for at-risk patients with symptoms, the first EU country to do so. The drug, marketed under the name of Lagevrio, received the green light for emergency use by the EMA in mid-November, allowing individual member states to decide for themselves whether to use it before official authorization.
Covid Merck pill, new data on effectiveness and FDA doubts about safety
“We recommend treatment with the pill because we believe the benefits outweigh the harms for those patients who are most at risk of becoming seriously ill with Covid,” explained Kirstine Moll Harboe of the Danish Health Authority. “At the same time we are fully aware that this is a new and unapproved treatment about which we don’t have much knowledge yet.”
Pfizer’s announcement: the pill also works against Omicron
Still on the front of Covid therapies, it should be remembered that in recent days Pfizer, with a statement by the CEO Albert Bourla, declared that its drug also works against the new Omicron variant.
Anti Covid pill Pfizer, the company’s announcement: “Also effective against Omicron”
.